Domestic Primary Antibody

Updated: 2026-08-06

Overview

Domestic primary antibody reagents are immunoglobulins produced in China, specifically designed to bind target antigens in research and diagnostic applications. These biological tools have gained significant market share due to competitive pricing and improving quality standards. Unlike secondary antibodies, primary antibodies directly recognize the antigen of interest, making them crucial for specific detection in techniques like Western blotting and immunohistochemistry. Manufacturers typically produce these reagents in mammalian host systems (rabbit, mouse, or goat) and purify them through affinity chromatography. The domestic industry has made notable advancements in recombinant antibody technology, offering alternatives to traditional polyclonal and monoclonal antibodies with better batch-to-batch consistency.

Physical and Chemical Properties

Primary antibody reagents are protein-based molecules with complex tertiary structures essential for antigen recognition. They maintain stability within pH 7.0-8.5 and are typically supplied in PBS or Tris-based buffers with carrier proteins (e.g., BSA) to prevent adsorption. The reagents demonstrate high specificity with dissociation constants (Kd) ranging from 10-7 to 10-11 M, depending on the antibody-antigen pair. Physical stability is temperature-dependent, with most products retaining activity for 1-2 years at -20°C. Repeated freeze-thaw cycles should be avoided as they can cause protein aggregation. The working concentration varies significantly (0.1-10 μg/mL) depending on application method and antigen abundance, requiring optimization for each experimental setup.

Main Applications

In research laboratories, these reagents are indispensable for protein detection and quantification. Western blotting accounts for approximately 40% of usage, followed by immunohistochemistry (30%) and ELISA (20%). Emerging applications include chromatin immunoprecipitation (ChIP) and proximity ligation assays, particularly in cancer research and drug development programs. The diagnostic sector utilizes domestic primary antibodies in clinical pathology for disease marker detection. Common targets include HER2 for breast cancer, CD markers for leukemia typing, and viral antigens in infectious disease testing. Compared to imported alternatives, domestic versions offer faster delivery and better accessibility for routine diagnostic panels in Chinese healthcare facilities.

Safety and Storage

Primary antibody reagents require careful handling to maintain integrity and prevent contamination. Always store aliquots at recommended temperatures and avoid repeated temperature fluctuations. Sodium azide (0.02-0.05%) is commonly added as a preservative, requiring precautions when handling concentrated stocks. For laboratories, implement proper waste disposal procedures for antibody-containing solutions. Although generally non-hazardous, some animal-derived antibodies may pose minimal zoonotic risk. Always consult safety data sheets (SDS) for specific handling requirements. For transportation, use insulated containers with cold packs, maintaining the cold chain to ensure product stability upon receipt.

B2B Procurement Guide

When sourcing domestic primary antibodies, prioritize manufacturers with ISO 13485 certification for in vitro diagnostics. Key evaluation criteria include: antibody specificity (validate with knockout controls), lot-to-lot consistency (request CoA for multiple batches), and technical support availability. Minimum order quantities typically range from 100μg to 1mg, with bulk discounts available for routine purchases. Leading domestic producers include ABclonal, Proteintech, and Sino Biological. Negotiate framework agreements for recurring needs, ensuring stable supply chains. For specialized targets, consider custom antibody development services, which domestic providers now offer at 30-50% lower costs than international competitors, with 4-6 month development timelines.